Cannabis Delivery Pilot in Graubünden
Zurich-based Astrasana Research AG has submitted an application for a pilot project for regulated cannabis distribution by mail. The canton of Graubünden is considered an ideal location.
Read more →Newsroom
Innovative insights and the latest news
The newsroom of Astrasana Holding AG keeps you informed at all times.
All articles
AST-Premium Line Flower Range Launches
Astrasana introduces its new AST-Premium Line of hand-selected medical cannabis flowers, now available in over twenty Swiss pharmacies.
Read more →
Swissmedic Cannabis Cultivation Licence
Astrasana Pharma AG has been granted a Swissmedic licence for the controlled cultivation of medical cannabis with THC content above 1%.
Read more →
GSI Creos Acquires Stake in Astrasana Japan
GSI Creos Corporation secures a 20% stake in Astrasana Japan Ltd., opening the door to Japan's newly legalised CBD food market.
Read more →
Curaleaf Expands into Czech Republic
Curaleaf International extends its Central European presence through a strategic partnership with Astrasana Pharma.
Read more →
Cantourage Launches Cannabis Flowers in CH
Cantourage Group and Astrasana jointly launch high-potency medical cannabis flowers for the Swiss market.
Read more →
Production Facility in Tagelswangen Complete
Astrasana successfully completes the setup of its pharmaceutical production facility in Tagelswangen, Canton Zurich.
Read more →
Clever Leaves International Supply Deal
Clever Leaves and Astrasana sign a supply agreement for the international distribution of medical cannabis.
Read more →
Joint Venture in Czech Republic
Astrasana expands into Central Europe with a new pharmaceutical joint venture for medical cannabis distribution in the Czech Republic.
Read more →
Stake in Leading Belgian Wholesaler
Strategic equity participation covering 70% market share in the Benelux region strengthens Astrasana's European distribution network.
Read more →
First Medical Cannabis Import by JV
Astrasana completes the first successful import of medical cannabis products through its Swiss pharmaceutical joint venture.
Read more →